Yarrow Bioscience, Inc. (YARW)
NASDAQ: YARW · Real-Time Price · USD
25.54
-0.53 (-2.03%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Yarrow Bioscience Employees
Yarrow Bioscience had 7 employees as of June 30, 2026.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$40,568,000
Market Cap
237.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 7 | - | - |
| Mar 31, 2026 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| ProQR Therapeutics | 187 |
| Lyell Immunopharma | 161 |
| AC Immune | 122 |
| Keros Therapeutics | 92 |
| Compugen | 75 |
| Cartesian Therapeutics | 75 |
| Sionna Therapeutics | 59 |
YARW News
- 13 days ago - Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares - Business Wire
- 17 days ago - Yarrow Bioscience 5.77M share Spot Secondary priced at $26.00 - TheFly
- 17 days ago - Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering - Business Wire
- 17 days ago - Yarrow Bioscience announces common stock offering, no amount given - TheFly
- 17 days ago - Yarrow Bioscience Announces Proposed Underwritten Public Offering - Business Wire
- 5 weeks ago - Yarrow Bioscience reported Q2 EPS ($2.14) - TheFly
- 6 weeks ago - Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 7 weeks ago - Yarrow Bioscience initiated with a Buy at BTIG - TheFly